Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Conditions: Platelet Aggregation; Type 2 Diabetes; Aspirin; Diabetes Mellitus, Type 2; Platelet Aggregation Inhibitors Interventions: Drug: Aspirin 81Mg Ec Tab twice daily for 7 days; Drug: Aspirin 40Mg Chew Tab twice daily for 7 days; Drug: Aspirin 162 mg EC Tab once daily for 7 days Sponsors: Montreal Heart Institute; Institut de Recherches Cliniques de Montreal Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials